Logotype for Loblaw Companies Limited

Loblaw Companies (L) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Loblaw Companies Limited

Q4 2025 earnings summary

27 Mar, 2026

Executive summary

  • Achieved consistent financial and operational performance in Q4 and full year 2025, driven by retail excellence, strategic investments in new stores, automation, and digital initiatives.

  • Adjusted diluted net earnings per common share grew 10.9% in Q4 2025 on a 12-week comparable basis, with revenue up 3.5% and gross profit percentage improving by 10 basis points.

  • Full-year 2025 retail revenue rose to CAD 63.9 billion, with adjusted diluted EPS up 13.6% year-over-year.

  • 77 new stores opened in 2025, and the first automated distribution center ramped up ahead of schedule.

  • Sale of PC Financial to EQ Bank announced; results now presented as discontinued operations, with future earnings reflecting proportional EQB ownership.

Financial highlights

  • Q4 revenue grew 3.5% year-over-year to CAD 15.5 billion (12-week comparable); full year revenue up 4.4% to CAD 63.7 billion.

  • Q4 2025 retail revenue: $16.4 billion, up 11.3% (13 weeks); up 3.5% on a 12-week comparable basis.

  • Adjusted EBITDA increased 4.8% to CAD 1.8 billion in Q4; margin improved by 10 bps to 11.5%.

  • Adjusted diluted EPS up 10.9% in Q4; reported EPS up 22% to CAD 0.67.

  • Full-year adjusted net earnings: $2.91 billion, up 10.5%; adjusted diluted EPS: $2.43, up 13.6%.

  • Free cash flow from retail operations: $1.24 billion in Q4; $1.91 billion for the year.

Outlook and guidance

  • 2026 plan targets continued consistent financial and operating performance, with new store investments similar to 2025 and increased Shoppers Drug Mart footprint.

  • Retail business expected to grow earnings faster than sales; adjusted EPS growth projected in high single digits, excluding PC Financial sale and 53rd week impacts.

  • Capital expenditures planned at approximately CAD 2.4 billion; most free cash flow to be returned to shareholders via dividends and buybacks.

  • Will open approximately 70 new food and drug stores and 30 new pharmacy care clinics in 2026.

  • Early 2026 shows continued momentum in same-store sales.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more